Inflammatory Response Research
This company develops a combination drug of levocetirizine and montelukast to treat inflammation caused by conditions like influenza. Their pharmaceutical product aims to help patients recover from inflammatory disorders.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops a combination drug of levocetirizine and montelukast to treat inflammation caused by conditions like influenza. Their pharmaceutical product aims to help patients recover from inflammatory disorders.